AstraZeneca PLC CEDEAR (AZND)
BCBA
Closed
Aug 24, 2026
Day's Range
42.5652 wk Range
37.30Overview - AZND - AstraZeneca PLC CEDEAR
Key Statistics
Valuation
Enterprise Value
836.59B
Price / Book
‪16.08‬
EV / EBITDA
‪42.03‬
Profitability
Profit Margin
‪17.02%‬
Operating Margin
‪23.45%‬
Return on Assets
‪8.01%‬
Return on Equity
‪21.96%‬
Ownership
Float
18.58B
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.0060%‬
Price stats
Beta
‪0.21‬
50-Day Avg
‪44.92‬
200-Day Avg
‪45.66‬
Dividends
Frequency
Semi-Annual
Peers - AZND - AstraZeneca PLC CEDEAR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on BCBA.
- AZNDBCBAAstraZeneca PLC CEDEAR+11.06%52-week change—P/E (Trailing)‪17.02%‬Profit Margin
- SANBCBABanco Santander, S.A. CEDEAR+43.62%52-week change60.24P/E (Trailing)‪33.46%‬Profit Margin
- JNJBCBAJohnson & Johnson CEDEAR+43.38%52-week change11.12P/E (Trailing)‪21.48%‬Profit Margin
- MRKBCBAMerck & Co., Inc. CEDEAR+52.12%52-week change2.59P/E (Trailing)‪4.76%‬Profit Margin
- LLYBCBAEli Lilly and Company CEDEAR+52.71%52-week change0.20P/E (Trailing)‪33.52%‬Profit Margin
- BIIBBCBABiogen Inc. CEDEAR+46.31%52-week change3.15P/E (Trailing)‪8.32%‬Profit Margin
- AMGNBCBAAmgen Inc.+43.97%52-week change0.19P/E (Trailing)‪22.95%‬Profit Margin
Profile Summary - AZND - AstraZeneca PLC CEDEAR
About
AstraZeneca PLC CEDEAR is a certificate representing shares of AstraZeneca PLC, a Swedish-British multinational pharmaceutical and biotechnology company headquartered in Cambridge, United Kingdom. The company focuses on the discovery, development, manufacture, and commercialization of prescription medicines across key…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
